News. 28/04/22

Procuritas partners with Nordic Biomarker

Procuritas Capital Investors (“Procuritas”) is pleased to announce that it has taken a majority stake in Nordic Biomarker, a fast-growing Swedish supplier of advanced reagents for IVD coagulation analyzers with a clear sustainability-driven purpose.  

Nordic Biomarker was founded in 2007 to meet market demand for an independent OEM-supplier of high-quality reagents for coagulation analyzers. The company has a growing product portfolio of routine and specialty reagents for IVD coagulation testing. In 2017, Nordic Biomarker teamed up with Medirox, adding CE-marked reagent kits to the product offering. Products are delivered to clients around the world for sale under their own brand names as well as to distributors of its portfolio of Medirox branded kits. Production is performed in-house at Nordic Biomarker’s new facilities in Umeå and in Linköping, Sweden. Nordic Biomarker is investing significantly in research and development of new products and has several new products in pipeline. The company had revenue of 131M SEK in 2021 and has approximately 80 employees. 

Procuritas has a strong track record of investing in companies that have the potential for transformational growth, in this instance to grow from a niche leader to a global challenger in coagulation testing through organic growth as well as M&A. The investment in Nordic Biomarker aligns with Procuritas’ target to support the UN Sustainable Development Goals and fits in with #3 “To ensure healthy lives and promote well-being at all ages”.  

Rikard Rodén, CEO, commented: “We are really proud to be partnering with Procuritas who have a fantastic track record of supporting businesses on their growth journey and making sure their potential is realized.  We have built up a great partnership over the past months and really look forward to working together.” 

Johan Conradsson, Co-Managing Partner at Procuritas, commented: “With our ageing population and the trend towards science-based health testing, we see great opportunities for Nordic Biomarker to continue its impressive journey. The company has high-quality products for patients and holds a unique and competitive position in a growing market. We see a great future for this business.”

For further information, please contact:

Johan Conradsson
johan.conradsson@procuritas.com

About Procuritas
Procuritas is a mid-market Nordic private equity investor, building up regional service champion and global niche leaders through transformative growth.  As the longest-established private equity firm in the Nordics with a 35-year track record, Procuritas has carefully invested in more than 45 companies, accelerated their growth and helped them to realize their true business potential. The long-serving team is characterized by its passion for business, hands-on experience, enthusiasm, commitment to ESG-linked value creation initiatives and strong belief that they are allies in the quest to build strong and sustainable businesses.  Read more at www.procuritas.com.  

About Nordic Biomarker
Nordic Biomarker is a Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation analyzers and offers products used for a wide range of routine and specialty tests. The company’s expertise covers all relevant technology areas, and prides itself on being experts when it comes to both immunological, chromogenic as well as clotting assays. Read more at www.nordicbiomarker.com. 

 

More news.

02/12/24

Procuritas exits its investment in Pierce Group AB (publ)

On Friday, November 29, 2024, Procuritas completed the sale of all its shares in Pierce Group AB (publ) to a limited number of investors including Siba Invest AB. Procuritas teamed up with the Pierce founders in 2014, attracted by its strong niche and leading market position in the Nordics, with great potential for expansion across...

01/11/24

Netcontrol appoints Sami Kurunsaari as CEO

Netcontrol has appointed Sami Kurunsaari as CEO, succeeding Tommi Roine. This leadership change is expected to guide the company forward as it continues its focus on innovation and growth in network automation. Sami Kurunsaari will officially join the company on January 1st, 2025. Netcontrol, a Finnish specialist in network automation, provides innovative solutions for the...

09/10/24

DSI Dantech acquires GEA’s North American freezing business

DSI Dantech has acquired GEA’s North American Freezing Business, constituting a significant milestone in becoming GEA’s North American partner for both new freezer sales and aftermarket services. GEA has chosen DSI Dantech as a partner based on its commitment to quality, technological excellence, and customer service. Following the acquisition of GEA’s IP for new machines...